Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.65M Sell
111,880
-19,415
-15% -$1.19M 0.03% 440
2026
Q1
$8.57M Sell
131,295
-14,736
-10% -$1.08M 0.04% 370
2025
Q4
$11.8M Buy
+146,031
New +$11.7M 0.06% 296
2025
Q1
$14.7M Sell
160,194
-825
-0.5% -$72K 0.08% 255
2024
Q4
$13.7M Buy
161,019
+3,239
+2% +$284K 0.07% 303
2024
Q3
$13.8M Buy
157,780
+24,442
+18% +$2.06M 0.07% 299
2024
Q2
$10.5M Sell
133,338
-83,946
-39% -$6.9M 0.05% 344
2024
Q1
$19.6M Buy
217,284
+1,247
+0.6% +$114K 0.1% 210
2023
Q4
$19M Sell
216,037
-7,926
-4% -$660K 0.1% 206
2023
Q3
$18.9M Sell
223,963
-4,689
-2% -$424K 0.11% 198
2023
Q2
$22M Sell
228,652
-414
-0.2% -$39K 0.12% 176
2023
Q1
$22M Sell
229,066
-87,941
-28% -$8.14M 0.12% 177
2022
Q4
$28.8M Sell
317,007
-51,388
-14% -$4.37M 0.17% 136
2022
Q3
$29.3M Sell
368,395
-16,378
-4% -$1.39M 0.18% 128
2022
Q2
$32.1M Sell
384,773
-63,047
-14% -$5.2M 0.19% 125
2022
Q1
$36.8M Sell
447,820
-6,603
-1% -$517K 0.18% 131
2021
Q4
$34M Sell
454,423
-2,473
-0.5% -$186K 0.16% 145
2021
Q3
$34.6M Sell
456,896
-1,502
-0.3% -$116K 0.18% 132
2021
Q2
$35.5M Sell
458,398
-2,915
-0.6% -$225K 0.18% 138
2021
Q1
$32.4M Buy
461,313
+309
+0.1% +$23.3K 0.17% 143
2020
Q4
$32.7M Sell
461,004
-51,337
-10% -$3.22M 0.18% 138
2020
Q3
$29.4M Buy
512,341
+169
+0% +$10.1K 0.18% 138
2020
Q2
$31.2M Sell
512,172
-105,430
-17% -$6.51M 0.19% 127
2020
Q1
$44.6M Hold
617,602
0.2% 138
2019
Q4
$44.6M Sell
617,602
-1,769
-0.3% -$120K 0.2% 138
2019
Q3
$40.9M Buy
619,371
+20,688
+3% +$1.33M 0.19% 148
2019
Q2
$37.2M Buy
598,683
+383,528
+178% +$22.2M 0.16% 173
2019
Q1
$11.6M Sell
215,155
-464,412
-68% -$26.1M 0.05% 351
2018
Q4
$39.8M Buy
679,567
+56,680
+9% +$3.55M 0.19% 147
2018
Q3
$41.1M Sell
622,887
-52,952
-8% -$3.5M 0.16% 195
2018
Q2
$44.7M Buy
675,839
+160,494
+31% +$10.8M 0.2% 168
2018
Q1
$33.7M Hold
515,345
0.14% 222
2017
Q4
$33.7M Buy
515,345
+33,250
+7% +$2.16M 0.14% 222
2017
Q3
$31M Buy
482,095
+5,991
+1% +$387K 0.14% 229
2017
Q2
$29M Hold
476,104
0.14% 231
2017
Q1
$29M Sell
476,104
-2,241
-0.5% -$135K 0.14% 231
2016
Q4
$27.9M Buy
478,345
+2,741
+0.6% +$162K 0.15% 231
2016
Q3
$27.5M Sell
475,604
-41,860
-8% -$2.47M 0.16% 233
2016
Q2
$29.9M Sell
517,464
-52,740
-9% -$3.02M 0.18% 190
2016
Q1
$34.5M Buy
570,204
+63,299
+12% +$3.54M 0.22% 134
2015
Q4
$27.7M Sell
506,905
-22,525
-4% -$1.29M 0.19% 161
2015
Q3
$30.1M Buy
529,430
+107,113
+25% +$6.13M 0.22% 134
2015
Q2
$23.1M Buy
422,317
+12,405
+3% +$682K 0.17% 210
2015
Q1
$22.3M Buy
409,912
+37,888
+10% +$1.91M 0.16% 207
2014
Q4
$17.4M Buy
372,024
+15,818
+4% +$741K 0.14% 240
2014
Q3
$16.3M Buy
356,206
+30,907
+10% +$1.45M 0.14% 225
2014
Q2
$15.1M Buy
325,299
+2,114
+0.7% +$99.6K 0.14% 229
2014
Q1
$15M Buy
323,185
+100,721
+45% +$4.4M 0.14% 214
2013
Q4
$9.17M Buy
222,464
+131,107
+144% +$5.16M 0.09% 282
2013
Q3
$3.35M Sell
91,357
-15,313
-14% -$579K 0.04% 431
2013
Q2
$3.96M Buy
+106,670
New +$3.81M 0.05% 384

Other funds holding DOX

Glenmede Trust's DOX Position: Q2 2026 in Review

Glenmede Trust reduced its Amdocs (DOX) stake by 15% in Q2 2026, selling an estimated $1.19M and leaving 111,880 shares worth $5.65M. The position accounts for 0.03% of the portfolio, ranked #440.

Glenmede Trust first reported a position in DOX in Q2 2013 and has held it in 51 quarters since. The position peaked at $44.7M in Q2 2018. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Glenmede Trust held 111,880 shares of Amdocs worth $5.65M as of Q2 2026.
  • Glenmede Trust sold 19,415 Amdocs shares in Q2 2026, an estimated $1.19M.
  • Amdocs made up 0.03% of Glenmede Trust's portfolio in Q2 2026, its #440 holding.
  • Glenmede Trust first reported a position in Amdocs in Q2 2013 and has held it in 51 quarters since.
  • Glenmede Trust's Amdocs position peaked at $44.7M in Q2 2018.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.